Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report

BACKGROUND: Sporadic lymphangioleiomyomatosis (LAM) is a rare form of diffuse parenchymal lung disease. PD-1 blocking antibodies constitute an essential treatment option for advanced non-small-cell lung cancer (NSCLC). The effect of immune checkpoint inhibitors in lymphangioleiomyomatosis patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pluvy, Johan, Brosseau, Solenn, Stelianides, Sandrine, Danel, Claire, Nguenang, Marina, Khalil, Antoine, Crestani, Bruno, Zalcman, Gérard, Gounant, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329093/
https://www.ncbi.nlm.nih.gov/pubmed/30634951
http://dx.doi.org/10.1186/s12890-018-0775-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329093/
https://www.ncbi.nlm.nih.gov/pubmed/30634951
http://dx.doi.org/10.1186/s12890-018-0775-5

Ejemplares similares